Skip to Main content Skip to Navigation
Journal articles

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma

Abstract : Background: Multiple myeloma (MM) is a heterogeneous plasma cell malignancy that remains challenging to cure. Global hypomethylation correlates with an aggressive phenotype of the disease, while hypermethylation is observed at particular regions of myeloma such as B cell-specific enhancers. The recently discovered active epigenetic mark 5-hydroxymethylCytosine (5hmC) may also play a role in tumor biology; however, little is known about its level and distribution in myeloma. In this study, we investigated the global level and the genomic localization of 5hmC in myeloma cells from 40 newly diagnosed patients, including paired relapses, and of control individuals. Results: Compared to normal plasma cells, we found global 5hmC levels to be lower in myeloma (P < 0.001). Higher levels of 5hmC were found in lower grades of the International Staging System prognostic index (P < 0.05) and tend to associate with a longer overall survival (P < 0.1). From the hydroxymethylome data, we observed that the remaining 5hmC is organized in large domains overlapping with active chromatin marks and chromatin opening. We discovered that 5hmC strongly persists at key oncogenic genes such as CCND1, CCND2 and MMSET and characterized domains that are specifically hydroxymethylated in myeloma subgroups. Novel 5hmC-enriched domains were found at puta-tive enhancers of CCND2 and MYC in newly diagnosed patients. Conclusions: 5hmC level is associated with clinical aspects of MM. Mapping 5hmC at a genome-wide level provides insights into the disease biology directly from genomic DNA, which makes it a potent mark to study epigenetics on large patient cohorts.
Document type :
Journal articles
Complete list of metadata

Cited literature [51 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-03006751
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, November 16, 2020 - 9:42:40 AM
Last modification on : Tuesday, November 17, 2020 - 3:21:43 AM
Long-term archiving on: : Wednesday, February 17, 2021 - 6:26:16 PM

File

Alberge2020_Article_DNAHydroxy...
Publisher files allowed on an open archive

Identifiers

Citation

Jean-Baptiste Alberge, Florence Magrangeas, Mirko Wagner, Soline Denié, Catherine Guérin-Charbonnel, et al.. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma. Clinical Epigenetics, BioMed Central, 2020, 12, pp.163. ⟨10.1186/s13148-020-00953-y⟩. ⟨inserm-03006751⟩

Share

Metrics

Record views

92

Files downloads

79